Healthcare & Life Sciences
Aptimmune Biologics
United Statesaptimmune.com
Aptimmune Biologics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Aptimmune Biologics
Aptimmune Biologics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Aptimmune Biologics develops mucosal vaccines targeting major viral diseases in swine, including Porcine Reproductive and Respiratory Syndrome virus (PRRSV), Swine Influenza A virus (IAV-S), and African Swine Fever virus (ASFV).
Explore Aptimmune Biologics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.